At the core of this agreement is a novel biocontrol product, based on the proprietary strain B2017 of Pseudomonas alloputida.

BBB is already working with ethicists and regulatory experts to ensure its technology is developed responsibly.

Pioneered by Italian ophthalmologist Benedetto Strampelli in the early 1960s, tooth-in-eye surgery is intended to minimize ...

The MetaVision3D tool transforms 2D tissue sections into 3D brain metabolome models, offering critical insights into ...

Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is proud to introduce its mission and vision to reshape global industries through ...

SAN DIEGO, CA - March 27, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is proud to introduce its mission and ...